公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2009 | Pars plana vitrectomy for diabetic fibrovascular proliferation with and without internal limiting membrane peeling | Chang P.-Y.; CHUNG-MAY YANG ; CHANG-HAO YANG ; MUH-SHY CHEN ; Wang J.-Y. | Eye | 23 | 20 | |
2023 | The pathological mechanisms and novel therapeutics for Leber's hereditary optic neuropathy | Yang, Yi-Ping; Foustine, Shania; Hsiao, Yu-Jer; Tsai, En-Tung; Tsai, Fu-Ting; Wang, Chia-Lin; Ko, Yu-Ling; Tai, Hsiao-Yun; Tsai, Yi-Ching; CHANG-HAO YANG ; Fu, Yun-Ju; Wang, An-Guor; Chien, Yueh | Journal of the Chinese Medical Association : JCMA | | | |
2000 | Pharmacokinetics of the fluocinolone/5-fluorouracil codrug in the gas-filled eye | Perkins S.L.; Gallemore R.P.; CHANG-HAO YANG ; Guo H.; Ashton P.; Jaffe G.J. | Retina | 21 | 8 | |
2001 | Pharmacokinetics of the ganciclovir implant in the silicone-filled eye | Perkins S.L.; CHANG-HAO YANG ; Ashton P.A.; Jaffe G.J. | Retina | 14 | 13 | |
2009 | Photodynamic therapy combined with posterior subtenon triamcinolone acetonide injection in the treatment of choroidal neovascularization | Lee Y.-A.; TZYY-CHANG HO ; MUH-SHY CHEN ; CHANG-HAO YANG ; CHUNG-MAY YANG | Eye | 6 | 7 | |
2012 | Photodynamic Therapy With or Without Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy: Two Years of Follow-Up | Lee Y.-A.; CHANG-HAO YANG ; CHUNG-MAY YANG ; TZYY-CHANG HO ; CHANG-PING LIN ; Huang J.-S.; MUH-SHY CHEN | American Journal of Ophthalmology | 49 | 43 | |
2019 | Polybenzyl glutamate biocompatible scaffold promotes the efficiency of retinal differentiation toward retinal ganglion cell lineage from human-induced pluripotent stem cells | TA-CHING CHEN ; She P.-Y.; Chen D.F.; Lu J.-H.; CHANG-HAO YANG ; Huang D.-S.; Chen P.-Y.; Lu C.-Y.; Cho K.-S.; Chen H.-F.; Su W.-F. | International Journal of Molecular Sciences | 19 | 15 | |
2003 | Posterior ischemic optic neuropathy following endoscopic sinus surgery | Huang T.-M.; Liu C.-M.; Cheng P.-W.; CHANG-HAO YANG | Otolaryngology - Head and Neck Surgery | 11 | 9 | |
2022 | PREDICTED PROTEIN STRUCTURE VARIATIONS INDICATE THE CLINICAL PRESENTATION OF CYP4V2 -RELATED BIETTI CRYSTALLINE DYSTROPHY | Chan, Li Wei; Sung, Yu Chi; Wu, Dung Chi; CHIEN-YU CHEN ; CHANG-HAO YANG ; CHUNG-MAY YANG ; PEI-LUNG CHEN ; TA-CHING CHEN | Retina | 4 | 3 | |
2019 | Prognostic factors for combined ranibizumab and prompt verteporfin photodynamic therapy for polypoidal choroidal vasculopathy | Hsia Y.; Chan L.-W.; CHANG-HAO YANG ; CHUNG-MAY YANG ; YI-TING HSIEH | Photodiagnosis and Photodynamic Therapy | 2 | 2 | |
2015 | Proteasome inhibitor bortezomib suppresses nuclear factor-kappa b activation and ameliorates eye inflammation in experimental autoimmune uveitis | Hsu S.-M.; CHANG-HAO YANG ; Shen F.-H.; Chen S.-H.; Lin C.-J.; Shieh C.-C. | Mediators of Inflammation | 20 | 16 | |
2020 | Protective effect of astaxanthin on blue light light-emitting diode-induced retinal cell damage via free radical scavenging and activation of PI3K/Akt/Nrf2 pathway in 661W cell model | CHAO-WEN LIN ; CHUNG-MAY YANG ; CHANG-HAO YANG | Marine Drugs | 19 | 14 | |
2018 | Protective effect of chitosan oligosaccharides on blue light light-emitting diode induced retinal pigment epithelial cell damage | CHAO-WEN LIN ; Huang H.-H.; CHUNG-MAY YANG ; CHANG-HAO YANG | Journal of Functional Foods | 12 | 10 | |
2020 | Protective effect of fenofibrate on oxidative stress-induced apoptosis in retinal–choroidal vascular endothelial cells: Implication for diabetic retinopathy treatment | Hsu Y.-J.; CHAO-WEN LIN ; Cho S.-L.; WEI-SHIUNG YANG ; CHUNG-MAY YANG ; CHANG-HAO YANG | Antioxidants | 16 | 15 | |
2013 | The Protective Effects of the Proteasome Inhibitor Bortezomib (Velcade) on Ischemia-Reperfusion Injury in the Rat Retina | Chen F.-T.; CHUNG-MAY YANG ; CHANG-HAO YANG | PLoS ONE | 31 | 25 | |
2022 | Quantitative analysis of branching neovascular networks in polypoidal choroidal vasculopathy by optical coherence tomography angiography after photodynamic therapy and anti-vascular endothelial growth factor combination therapy | Wang W.-Y.; CHANG-HAO YANG ; TA-CHING CHEN ; YI-TING HSIEH ; TZYY-CHANG HO ; CHUNG-MAY YANG ; Liu F.-Y.; TSO-TING LAI | Graefe's Archive for Clinical and Experimental Ophthalmology | 3 | 2 | |
2021 | Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy | Ma I.-H.; Hsia Y.; YI-TING HSIEH ; TZYY-CHANG HO ; TSO-TING LAI ; CHUNG-MAY YANG ; CHANG-HAO YANG | Scientific Reports | 3 | 3 | |
2024 | Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study | Giocanti-Aurégan, Audrey; Donati, Simone; Hoerauf, Hans; Allmeier, Helmut; Rittenhouse, Kay D; Machewitz, Tobias; CHANG-HAO YANG | Ophthalmology and therapy | | | |
2023 | Refining vitrectomy for proliferative diabetic retinopathy | Chen, San Ni; Chen, Shih Jen; Wu, Tsung Tien; Wu, Wei Chi; CHANG-HAO YANG ; CHUNG-MAY YANG | Graefe's Archive for Clinical and Experimental Ophthalmology | 1 | 0 | |
2010 | Regulation of Cyr61/CCN1 expression by hypoxia through cooperation of c-Jun/AP-1 and HIF-1α in retinal vascular endothelial cells | You J.-J.; CHUNG-MAY YANG ; MUH-SHY CHEN ; CHANG-HAO YANG | Experimental Eye Research | 38 | 33 | |